ATO + Ascorbic acid for myelodysplastic syndromes

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Trial registered. A trial in people is registered. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 5 Dec 2008: Trial registered, NCT00803530

The trials

NCT00803530: Study of Association of Arsenic Trioxide (ATO) and Ascorbic Acid in Myelodysplastic Syndromes

State
Stopped early
Phase
Phase 2
People
55 planned
Started
Sep 2005
Primary completion
Jan 2007
Arms
1
Results
None posted
  1. 5 Dec 2008: Trial registered

How the status changed

  1. 19 Nov 2026: First set: Trial registered

About the treatment

Kind of treatment: Drug.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.